CNMD vs LEN · P/E 19, rev $1.31B vs rev $34.19B
CONMED Corporation (CNMD) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
CONMED Corporation (CNMD) is a medical devices company listed on NYSE.
LEN (LEN) common stock.
Latest reported CNMD revenue for 2024-12-31 was $1.31B. Net income was $132.4M. Revenue was up 5.0% from 2023-12-31 to 2024-12-31. CNMD currently screens at market cap $1.04B and trailing P/E 19.3.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CNMD currently screens at market cap $1.04B and trailing P/E 19.3. LEN currently screens at market cap $0.
Not investment advice. Open the CNMD and LEN stock pages for the full models.
Not investment advice.